Title Evaluation of Surrogate Endpoints in Clinical Trials
نویسندگان
چکیده
May 15, 2015 Type Package Title Evaluation of Surrogate Endpoints in Clinical Trials Version 0.1-6 Date 2015-05-14 Author Wim Van der Elst, Ariel Alonso & Geert Molenberghs Maintainer Wim Van der Elst Description In a clinical trial, it frequently occurs that the most credible outcome to evaluate the effectiveness of a new therapy (the true endpoint) is difficult to measure. In such a situation, it can be an effective strategy to replace the true endpoint by a biomarker that is easier to measure and that allows for a prediction of the treatment effect on the true endpoint (a surrogate endpoint). The package 'Surrogate' allows for an evaluation of the appropriateness of a candidate surrogate endpoint based on the meta-analytic, informationtheoretic, and causal-inference frameworks. Part of this software has been developed using funding provided from the European Union's 7th Framework Programme for research, technological development and demonstration under Grant Agreement no 602552. Depends MASS, nlme, msm, lme4 Imports rgl, lattice, latticeExtra License GPL (>= 2) BugReports Wim Van der Elst Repository CRAN NeedsCompilation no Date/Publication 2015-05-15 00:12:46
منابع مشابه
Statistical Issues in Evaluation of Surrogate Endpoints
Among the most important issues in the design of a clinical trial is the selection of the primary endpoint. Fleming et al. (1998) provided two criteria to govern its selection: the endpoint should be (i) sensitive to treatment effects, and (ii) clinically relevant. Endpoints that directly reflect how a patient feels, functions, or survives have clear clinical relevance; we refer to these as tru...
متن کاملEvaluation of the Quality of Writing of the Title and Abstract of Randomized Controlled Clinical Trial Papers Published in the Journals of the Iran,s Universities of Medical Sciences in 2016, Based on the CONSORT Checklist: A Descriptive Study
Background and Objectives: Given the fact that randomized controlled clinical trials are more valid than other research methods to determine the therapeutic effects of treatment, proper design and accurate reporting is of particular importance. This study was conducted with the aim of evaluating the quality of writing the title and abstract of randomized clinical trials of Iranian medical unive...
متن کاملA unified framework for the evaluation of surrogate endpoints in mental-health clinical trials.
For a number of reasons, surrogate endpoints are considered instead of the so-called true endpoint in clinical studies, especially when such endpoints can be measured earlier, and/or with less burden for patient and experimenter. Surrogate endpoints may occur more frequently than their standard counterparts. For these reasons, it is not surprising that the use of surrogate endpoints in clinical...
متن کاملPackage ‘ Surrogate ’
August 18, 2017 Type Package Title Evaluation of Surrogate Endpoints in Clinical Trials Version 0.4 Date 2017-08-18 Author Wim Van der Elst, Paul Meyvisch, Ariel Alonso, Hannah M. Ensor, Christopher J. Weir & Geert Molenberghs Maintainer Wim Van der Elst Description In a clinical trial, it frequently occurs that the most credible outcome to evaluate the effectiveness ...
متن کاملTwo Decades of Cardiovascular Trials With Primary Surrogate Endpoints: 1990–2011
BACKGROUND Surrogate endpoint trials test strategies more efficiently but are accompanied by uncertainty about the relationship between changes in surrogate markers and clinical outcomes. METHODS AND RESULTS We identified cardiovascular trials with primary surrogate endpoints published in the New England Journal of Medicine, Lancet, and JAMA: Journal of the American Medical Association from 1...
متن کامل